Warburg Pincus has held a final close on its latest growth equity fund at $17 billion, exceeding its $15 billion target. The fund will invest in high-growth businesses across healthcare, technology, and financial services.
Warburg Pincus Global Growth Fund XIV closed with commitments from 185 institutional investors across 32 countries, reflecting sustained appetite for growth equity strategies despite broader fundraising headwinds. Approximately 35% of capital came from Asia-Pacific investors, underlining the firm's strong track record in the region.
The fund will maintain Warburg Pincus's hallmark sector diversification, with planned allocations of approximately 30% to healthcare, 25% to technology, 20% to financial services, and 25% across energy, consumer, and industrial sectors. Geographic exposure will tilt toward the U.S. and India, where the firm has historically generated its strongest returns.
Co-CEO Jeff Perlman highlighted India as a particularly fertile ground for growth equity deployment: "India is experiencing a structural acceleration in digital infrastructure, financial inclusion, and healthcare access. We see a pipeline of 15-20 potential investments over the next 24 months."
The growth equity segment has proven more resilient than buyout fundraising in the current cycle, as LPs favor strategies that deploy smaller check sizes into high-growth companies with lower leverage. Competitors including General Atlantic, TA Associates, and Summit Partners have also raised large growth funds in the past 12 months.
Warburg Pincus's prior fund, Global Growth XIII, raised $16 billion in 2021 and has generated a 1.6x gross MOIC driven by strong exits in Indian financial services and Southeast Asian e-commerce. The firm's historical growth equity funds have delivered net IRRs in the 18-22% range across vintage years.
Get the latest private equity news, deal analysis, and market insights. Browse by category or explore our research tools.